Ashish M Kamat

Ashish M Kamat

UNVERIFIED PROFILE

Are you Ashish M Kamat?   Register this Author

Register author
Ashish M Kamat

Ashish M Kamat

Publications by authors named "Ashish M Kamat"

Are you Ashish M Kamat?   Register this Author

100Publications

1683Reads

32Profile Views

Does Variant Histology Change Management of Non-muscle-invasive Bladder Cancer?

Eur Urol Oncol 2019 Aug 5. Epub 2019 Aug 5.

Johns Hopkins University, School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.06.012DOI Listing
August 2019

Advances in risk stratification of bladder cancer to guide personalized medicine.

F1000Res 2018 25;7. Epub 2018 Jul 25.

Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Suite 853, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.14903.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069735PMC
July 2019

Effect of Immunotherapy on Local Treatment of Genitourinary Malignancies.

Eur Urol Oncol 2019 Jul 31;2(4):355-364. Epub 2019 Jan 31.

Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.01.002DOI Listing
July 2019

How Should I Manage a Patient with Tumor Recurrence Despite Adequate Bacille Calmette-Guérin?

Eur Urol Oncol 2019 Jul 12. Epub 2019 Jul 12.

Urology Oncology, Fundacoió Puigvert, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.06.013DOI Listing
July 2019

Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars Series.

Urol Oncol 2019 Jul 31. Epub 2019 Jul 31.

Department of Urology, Friedrich-Alexander University, Erlangen, Germany; Urologie 24, Nürnberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2019.06.025DOI Listing
July 2019

The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.

Urol Oncol 2019 Jun 28;37(6):353.e17-353.e24. Epub 2019 Jan 28.

Department of Urology, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2019.01.020DOI Listing
June 2019

Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.

Eur Urol Oncol 2019 May 10;2(3):286-293. Epub 2018 Sep 10.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2018.08.013DOI Listing
May 2019

Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record study.

Future Oncol 2019 Apr 3;15(12):1323-1334. Epub 2019 Apr 3.

Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0654DOI Listing
April 2019

New horizons in bladder cancer research.

Urol Oncol 2019 Mar 7. Epub 2019 Mar 7.

Department of Urology, Friedrich-Alexander University, Erlangen, Germany; MVZ Urologie 24, Nuremberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439183050
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2018.12.014DOI Listing
March 2019

The role of metastatic burden in cytoreductive/consolidative radical cystectomy.

World J Urol 2019 Mar 12. Epub 2019 Mar 12.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-019-02693-yDOI Listing
March 2019

Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer-Reply.

JAMA Surg 2019 Feb;154(2):186

Department of Surgery, The University of Texas Medical Branch, Galveston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamasurg.2018.4372DOI Listing
February 2019

Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.

Curr Oncol Rep 2019 Feb 26;21(3):23. Epub 2019 Feb 26.

Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1373, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-019-0772-8DOI Listing
February 2019

Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease.

Eur Urol 2019 01 6;75(1):8-10. Epub 2018 Oct 6.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183071
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.09.028DOI Listing
January 2019

Editorial: Basic research in bladder cancer - refining the tools. 3rd IBCN seminars series.

Urol Oncol 2019 Jan 22. Epub 2019 Jan 22.

Department of Urology and Pediatric Urology, Friedrich-Alexander University, Erlangen, Germany; MVZ Urologie 24, Nürnberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2019.01.003DOI Listing
January 2019

Salvage topical therapy for upper tract urothelial carcinoma.

World J Urol 2018 Dec 26;36(12):2027-2034. Epub 2018 May 26.

Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-018-2349-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261784PMC
December 2018

Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations.

Eur Urol 2018 11 13;74(5):597-608. Epub 2018 Jul 13.

Division of Urology, Department of Surgery, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.06.024DOI Listing
November 2018

Editorial comment.

Curr Opin Urol 2018 11;28(6):555-556

Molinette Hospital, University of Turin School of Medicine, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000551DOI Listing
November 2018

Hospital length of stay following radical cystectomy for muscle-invasive bladder cancer: Development and validation of a population-based prediction model.

Urol Oncol 2018 Nov 13. Epub 2018 Nov 13.

Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439183043
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2018.10.024DOI Listing
November 2018

Treatment Options for Patients with Recurrent Tumors After BCG Therapy: Are We Ignoring the Obvious?

Eur Urol 2018 10 22;74(4):405-408. Epub 2018 Apr 22.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183027
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.04.012DOI Listing
October 2018

Current Use and Promise of Urinary Markers for Urothelial Cancer.

Curr Urol Rep 2018 Oct 17;19(12):96. Epub 2018 Oct 17.

The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 1373, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11934-018-0857-1
Publisher Site
http://dx.doi.org/10.1007/s11934-018-0857-1DOI Listing
October 2018

Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future.

Urol Oncol 2018 09 8;36(9):413-422. Epub 2017 Nov 8.

Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.10.014DOI Listing
September 2018

Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars series.

Urol Oncol 2018 09 13;36(9):403-404. Epub 2018 Mar 13.

Department of Urology, Friedrich-Alexander University, Erlangen, Germany; MVZ Urologie24, Nürnberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.11.006DOI Listing
September 2018

Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases.

Hum Pathol 2018 09 12;79:57-65. Epub 2018 May 12.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.05.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133751PMC
September 2018

Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With Chemotherapy.

Clin Genitourin Cancer 2018 08 27;16(4):e909-e917. Epub 2018 Mar 27.

Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2018.03.002DOI Listing
August 2018

Role of Checkpoint Inhibition in Localized Bladder Cancer.

Eur Urol Oncol 2018 Aug 30;1(3):190-198. Epub 2018 May 30.

Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2018.05.002DOI Listing
August 2018

Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer.

Eur Urol Oncol 2018 Aug 17. Epub 2018 Aug 17.

Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2018.07.009DOI Listing
August 2018

Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort.

Eur Urol Focus 2018 Jul 19. Epub 2018 Jul 19.

Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2018.07.001DOI Listing
July 2018

New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21-23, 2017.

Bladder Cancer 2018 Jul 30;4(3):339-342. Epub 2018 Jul 30.

Department of Urology and Pediatric Urology, Friedrich-Alexander University, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BLC-189032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087445PMC
July 2018

Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-muscle-invasive Bladder Cancer.

Eur Urol Focus 2018 07 3;4(4):512-521. Epub 2018 Sep 3.

Division of Urology, The University of Texas Medical Branch, Galveston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2018.08.019DOI Listing
July 2018

Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.

Eur Urol 2018 06 6;73(6):925-933. Epub 2018 Mar 6.

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.02.014DOI Listing
June 2018

Welcome to European Urology Oncology: Your New Journal, Where Multiple Disciplines Meet To Improve Care of Patients with Genitourinary Cancers.

Eur Urol Oncol 2018 May 15;1(1):1-2. Epub 2018 May 15.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2018.04.002DOI Listing
May 2018

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review.

Eur Urol 2018 04 7;73(4):543-557. Epub 2017 Nov 7.

Department of Urology, Medical University of Vienna, Vienna, Austria; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.09.030DOI Listing
April 2018

Effects of thiazolidinedione in patients with active bladder cancer.

BJU Int 2018 02 23;121(2):244-251. Epub 2017 Sep 23.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780258PMC
February 2018

It's all about the perspective: Removing bias when co-managing patients with high-grade T1 bladder cancer and localized prostate cancer-A competing risks analysis.

Urol Oncol 2018 02 20;36(2):39-42. Epub 2017 Nov 20.

Department of Urology, MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.10.019DOI Listing
February 2018

Secondary Tumors After Urinary Diversion.

Urol Clin North Am 2018 Feb;45(1):91-99

Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1373, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2017.09.010DOI Listing
February 2018

Contribution of bladder cancer pathology assessment in planning clinical trials.

Urol Oncol 2018 Feb 1. Epub 2018 Feb 1.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2018.01.001DOI Listing
February 2018

The Blebbishield Emergency Program Overrides Chromosomal Instability and Phagocytosis Checkpoints in Cancer Stem Cells.

Cancer Res 2017 11 30;77(22):6144-6156. Epub 2017 Aug 30.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-0522DOI Listing
November 2017

Should we care more about SPARE?

BJU Int 2017 11;120(5):605-606

Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13953DOI Listing
November 2017

Strategies to minimize readmission rates following major urologic surgery.

Ther Adv Urol 2017 Oct 11;9(5):111-119. Epub 2017 Apr 11.

University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit #1373, Houston, TX 77030-4000, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756287217701699DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444623PMC
October 2017

Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.

J Clin Oncol 2017 Oct 23;35(30):3410-3416. Epub 2017 Aug 23.

Neal D. Shore, Carolina Urologic Research Center, Myrtle Beach, SC; Stephen A. Boorjian, Mayo Clinic, Rochester, MN; Daniel J. Canter, Ochsner Health System, New Orleans, LA; Kenneth Ogan, Emory University, Atlanta, GA; Lawrence I. Karsh, The Urology Center of Colorado, Denver, CO; Tracy M. Downs, University of Wisconsin, Madison, WI; Leonard G. Gomella, Thomas Jefferson University, Philadelphia, PA; Ashish M. Kamat and Colin P.N. Dinney, University of Texas MD Anderson Cancer Center; Seth P. Lerner, Baylor College of Medicine, Houston; Yair Lotan, University of Texas Southwestern Medical Center, Dallas; Robert S. Svatek, University of Texas Health Science Center at San Antonio, San Antonio, TX; Trinity J. Bivalacqua, Johns Hopkins School of Medicine, Baltimore, MD; Robert L. Grubb III, Washington University, St Louis, MO; Tracey L. Krupski, University of Virginia, Charlottesville, VA; Michael E. Woods and Matthew I. Milowsky, University of North Carolina, Chapel Hill; Brant A. Inman, Duke University, Durham, NC; Alan Boyd, Alan Boyd Consultants, Cottenham; F. Peter Treasure, Peter Treasure Statistical Services, King's Lynn, United Kingdom; Gillian Gregory, David G. Sawutz, and Nigel R. Parker, FKD Therapies Oy; and Seppo Yla-Herttuala, A.I. Virtanen Institute University of Eastern Finland and Science Service Center and Gene Therapy Unit, Kuopio, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.3064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648171PMC
October 2017

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

J Urol 2017 09 26;198(3):552-559. Epub 2017 Apr 26.

American Urological Association Education and Research, Inc., Linthicum, Maryland; American Society of Clinical Oncology, Alexandria, Virginia; American Society for Radiation Oncology, Arlington, Virginia; Society of Urologic Oncology, Inc., Schaumburg, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.04.086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626446PMC
September 2017

Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.

J Oncol Pract 2017 09 10;13(9):621-625. Epub 2017 Aug 10.

Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Oregon Health & Science University School of Medicine, Portland, OR; University of Virginia, Charlottesville, VA; MD Anderson Cancer Center; Baylor College of Medicine, Houston; UT Southwestern, Dallas, TX; Northwestern University, Chicago, IL; Washington University School of Medicine, Saint Louis, MO; University of Michigan, Ann Arbor, MI; Bladder Cancer Advocacy Network, Bethesda, MD; Massachusetts General Hospital, Salem, MA; and Kansas University Medical Center, Kansas City, KS.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.024919DOI Listing
September 2017

High-grade neuroendocrine carcinoma of the urachus-report of 3 cases.

Hum Pathol 2017 09 18;67:126-133. Epub 2017 Aug 18.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2017.08.003DOI Listing
September 2017

Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis.

Sci Rep 2017 08 29;7(1):9602. Epub 2017 Aug 29.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-08796-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575243PMC
August 2017

Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease.

Bladder Cancer 2017 Jul 27;3(3):147-148. Epub 2017 Jul 27.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BLC-179020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545908PMC
July 2017

Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration.

Drugs R D 2017 Jun;17(2):297-304

Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40268-017-0183-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427054PMC
June 2017

CFDODA-Me induces apoptosis, degrades Sp1, and blocks the transformation phase of the blebbishield emergency program.

Apoptosis 2017 05;22(5):719-729

Department of Urology, Unit 1373, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10495-017-1359-1
Publisher Site
http://dx.doi.org/10.1007/s10495-017-1359-1DOI Listing
May 2017

Bladder cancer: 2017 and beyond.

Authors:
Ashish M Kamat

Indian J Urol 2017 Apr-Jun;33(2):104-105

Department of Urology, The University of Texas MD Anderson Cancer Center, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0970-1591.203419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396396PMC
May 2017

RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program.

Cell Death Discov 2017 29;3:17023. Epub 2017 May 29.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/cddiscovery201723
Publisher Site
http://dx.doi.org/10.1038/cddiscovery.2017.23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447132PMC
May 2017

Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer.

Eur Urol Focus 2017 04 13;3(2-3):258-264. Epub 2016 May 13.

Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2016.04.008DOI Listing
April 2017

BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG.

Nat Rev Urol 2017 Apr 21;14(4):244-255. Epub 2017 Feb 21.

Department of Urology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HGB, Nijmegen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2017.16DOI Listing
April 2017

CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer.

Bladder Cancer 2017 Apr 27;3(2):79-88. Epub 2017 Apr 27.

Department of Urology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BLC-170105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409046PMC
April 2017

Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

World J Urol 2017 Mar 21;35(3):337-353. Epub 2016 Apr 21.

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-016-1826-2DOI Listing
March 2017

Blebbishields and mitotic cells exhibit robust macropinocytosis.

Biofactors 2017 Mar 27;43(2):181-186. Epub 2016 Sep 27.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/biof.1335DOI Listing
March 2017

What is new in non-muscle-invasive bladder cancer in 2016?

Turk J Urol 2017 Mar 1;43(1):9-13. Epub 2017 Mar 1.

Department of Urology, Hacettepe University School of Medicine, Ankara, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5152/tud.2017.60376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330275PMC
March 2017

Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients.

Bladder Cancer 2017 Jan 27;3(1):65-71. Epub 2017 Jan 27.

Department of Urology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BLC-160084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271425PMC
January 2017

Bladder cancer.

Lancet 2016 12 23;388(10061):2796-2810. Epub 2016 Jun 23.

Department of Surgery (Urology), McGill University Health Center, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)30512-8DOI Listing
December 2016

New discoveries in the molecular landscape of bladder cancer.

F1000Res 2016 19;5:2875. Epub 2016 Dec 19.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.10031.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225406PMC
December 2016

The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy.

World J Urol 2016 Nov 4;34(11):1561-1566. Epub 2016 Mar 4.

Department of Urology, The University of Kansas Medical Center, 3901 Rainbow Blvd, MS 3016, Kansas City, KS, 66160, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-016-1801-yDOI Listing
November 2016

Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.

Urol Oncol 2016 10 29;34(10):460-8. Epub 2016 Jun 29.

Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.05.028DOI Listing
October 2016

Innovation in Bladder Cancer Immunotherapy.

J Immunother 2016 10;39(8):291-7

*The University of Texas MD Anderson Cancer Center, Houston, TX †BCG Oncology, Phoenix, AZ ‡Merck Research Laboratories, Kenilworth, NJ §University of Connecticut Health Center, Farmington, CT ∥Unité d'Immunobiologie des Cellules Dendritiques, Department of Immunology, Institut Pasteur and INSERM U1223, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000130DOI Listing
October 2016

Taking the next step-Advancing bladder cancer management.

Urol Oncol 2016 10;34(10):435-6

Department of Urology, Friedrich-Alexander University, Erlangen, Germany; Urologie(24)/Urology Schön Klinik Nürnberg Fürth, Fürth, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.03.004DOI Listing
October 2016

CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species.

Urol Oncol 2016 08 30;34(8):337.e11-8. Epub 2016 Mar 30.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.02.025DOI Listing
August 2016

Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study.

Medicine (Baltimore) 2016 Aug;95(31):e4500

aDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA bDepartment of Biostatistics and Epidemiology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan cDepartment of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA dDepartment of Anatomic Pathology, Tokyo Medical University, Tokyo eDepartment of Clinical Sciences and Laboratory Medicine, Kansai Medical University, Hirakata, Osaka fDepartment of Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000004500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979853PMC
August 2016

Corrigendum re: "Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin" [Eur Urol 2016;69:197-200].

Authors:
Ashish M Kamat

Eur Urol 2016 07 4;70(1):e26. Epub 2016 Mar 4.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.02.059DOI Listing
July 2016

Novel PKC-ζ to p47 phox interaction is necessary for transformation from blebbishields.

Sci Rep 2016 Apr 4;6:23965. Epub 2016 Apr 4.

Department of Urology, Unit 1373, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep23965DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819220PMC
April 2016

The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer - A New Analysis.

Bladder Cancer 2016 Apr 27;2(2):273-278. Epub 2016 Apr 27.

Department of Urology, University of Texas M D Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BLC-160048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927917PMC
April 2016

Endocytosis and serpentine filopodia drive blebbishield-mediated resurrection of apoptotic cancer stem cells.

Cell Death Discov 2016;2. Epub 2016 Jan 25.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cddiscovery.2015.69DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876976PMC
January 2016